Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparison of INNO-LIPA and TRUGENE assays for genotyping and drug-resistance mutations in chronic hepatitis B virus infection.

Intervirology - 1 Jan 2013

Basaras Miren, Arrese Elisabete, Blanco Sonia, Arroyo L Sara, Ruiz Pablo, Cisterna Ramón

Abstract excerpt

OBJECTIVE: Hepatitis B virus (HBV) genotyping and detection of resistance to drugs have become essential in epidemiological and clinical diagnosis. Our main objective was to determine the prevalence of HBV genotypes and drug-resistance mutations in chronic asymptomatic carriers and chronic HBV sufferers comparing 2 detection assays. METHODS: Serum samples from 28 chronic HBV patients and 22 chronic asymptomatic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Carrier State

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to Hepatitis B, Chronic

Share to Hepatitis B virus

Share to Molecular Diagnostic Techniques

Share to Virology

Source

Identifiers

PMID: 23594698
DOI: 10.1159/000348502

Genes

LIPA

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparison of INNO-LIPA and TRUGENE assays for genotyping and drug-resistance mutations in chronic hepatitis B virus infection.PMID 23594698Read ↗

Sensitive line probe assay that simultaneously detects mutations conveying resistance to lamivudine and adefovir.Semantic proximity Read ↗

Role of the line probe assay INNO-LiPA HBV DR and ultradeep pyrosequencing in detecting resistance mutations to nucleoside/nucleotide analogues in viral samples isolated from chronic hepatitis B patients.Semantic proximity Read ↗

Validation of the INNO-LiPA HBV DR assay (version 2) in monitoring hepatitis B virus-infected patients receiving nucleoside analog treatment.Semantic proximity Read ↗

Comparison of sequence analysis and the INNO-LiPA HBV DR line probe assay for detection of lamivudine-resistant hepatitis B virus strains in patients under various clinical conditions.Semantic proximity Read ↗

Evaluation of the INNO-LiPA HBV genotyping assay for determination of hepatitis B virus genotype.Semantic proximity Read ↗

Use of the novel INNO-LiPA line probe assay for detection of hepatitis B virus variants that confer resistance to entecavir therapy.Semantic proximity Read ↗

Development of hepatitis C virus genotyping by real-time PCR based on the NS5B region.Semantic proximity Read ↗

Monitoring drug resistance in chronic hepatitis B virus (HBV)-infected patients during lamivudine therapy: evaluation of performance of INNO-LiPA HBV DR assay.Semantic proximity Read ↗

Lamivudine and Adefovir Motif Variants Detected in chronic Hepatıtıs B patients.Semantic proximity Read ↗

Hepatitis B viral genotyping with the research INNO-LiPA HBV genotyping line probe assay.Semantic proximity Read ↗

Comparison of three different HCV genotyping methods: core, NS5B sequence analysis and line probe assay.Semantic proximity Read ↗

Fast and Sensitive Real-Time PCR Detection of Major Antiviral-Drug Resistance Mutations in Chronic Hepatitis B Patients by Use of a Predesigned Panel of Locked-Nucleic-Acid TaqMan Probes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.